D. Stewart

发表

A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients.

L. Seymour, W. Miller, G. Batist, 2003, Clinical Cancer Research.

In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.

G. Bodey, D. Stewart, 1971, Applied microbiology.

In vitro studies of a new semisynthetic penicillin, 6-(d-alpha-sulfoaminophenylacetamido)-penicillanic acid.

G. Bodey, D. Stewart, 1969, Applied microbiology.

A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131.

K. Gelmon, D. Ayers, L. Seymour, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy

F. Shepherd, D. Walde, L. Yelle, 1995, Supportive Care in Cancer.

ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.

D. Jonker, L. Avruch, D. Stewart, 2011, Anticancer research.

In Vitro Studies of BB-K8, a New Aminoglycoside Antibiotic

G. Bodey, D. Stewart, 1973, Antimicrobial Agents and Chemotherapy.

New Drugs for the Treatment of Soft Tissue Sarcomas

R. Benjamin, L. Baker, G. Bodey, 1980 .

Investigational Drug Steering Committee Trial Design Task Force of the National Cancer Institute Therapeutics : Consensus Recommendations from the Clinical The Design of Phase II Clinical Trials Testing Cancer

D. Berry, J. Crowley, S. Groshen, 2010 .

Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

E. Eisenhauer, P. Band, K. Pritchard, 1986, Cancer treatment reports.

Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.

E. Eisenhauer, P. Band, D. Stewart, 1986, Cancer treatment reports.

Multicenter Phase II Study of Brequinar Sodium in Patients with Advanced Breast Cancer

R. Cody, M. Moore, N. Azarnia, 1993, American journal of clinical oncology.

Phase II trial of mitogauzone in malignant primary brain tumors.

W. Yung, N. Savaraj, L. Feun, 1985, Cancer treatment reports.

Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group

E. Eisenhauer, P. Forsyth, G. Cairncross, 2004, Investigational New Drugs.

A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, R. Wierzbicki, D. Stewart, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

In Vitro Studies of Netilmicin, a New Aminoglycoside Antibiotic

G. Bodey, D. Stewart, B. Leblanc, 1977, Antimicrobial Agents and Chemotherapy.

Infections in hairy cell leukemia (leukemic reticuloendotheliosis)

G. Bodey, D. Stewart, 1981, Cancer.

Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.

K. Bélanger, L. Seymour, J. Jimeno, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility of Administering Aminoglycoside Antibiotics by Continuous Intravenous Infusion

G. Bodey, D. Stewart, V. Rodriguez, 1975, Antimicrobial Agents and Chemotherapy.

Azlocillin: In Vitro Studies of a New Semisynthetic Penicillin

G. Bodey, D. Stewart, 1977, Antimicrobial Agents and Chemotherapy.

Clinical Pharmacological Studies of Carbenicillin

G. Bodey, D. Stewart, V. Rodriguez, 1969, The American journal of the medical sciences.

Clinical Pharmacology of Netilmicin

G. Bodey, B. Yap, D. Stewart, 1977, Antimicrobial Agents and Chemotherapy.

In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.

G. Bodey, D. Stewart, 1975, The Journal of antibiotics.

In Vitro Studies of Tobramycin

G. Bodey, D. Stewart, 1972, Antimicrobial Agents and Chemotherapy.

Phase I study of 3-deazauridine in the treatment of adults with solid tumors.

B. Barlogie, R. Benjamin, M. Burgess, 1980, Cancer treatment reports.

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

P. Wells, M. Rodger, T. Ramsay, 2019, The New England journal of medicine.

Two-Year Efficacy and Safety of Simvastatin 80 mg in Familial Hypercholesterolemia (The Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia (ExPRESS FH))

D. Stewart, A. Petrich, S. Chong, 2002 .

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, M. Moore, D. Stewart, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparative in vitro activity of cephalosporins.

G. Bodey, D. Stewart, 1976, The Journal of antibiotics.

Phase I clinical trial of Exherin (ADH-1) in patients with advanced solid tumors.

D. Jonker, L. Avruch, D. Stewart, 2013, Current clinical pharmacology.

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.

D. Johnston, D. Osoba, F. Shepherd, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Susan Groshen, Larry Rubinstein, Lesley Seymour, 2010, Clinical Cancer Research.

Phase I clinical study of didemnin B

E. Eisenhauer, J. Maroun, D. Stewart, 1998, Investigational New Drugs.

A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors

R. Benjamin, N. Savaraj, L. Feun, 1983, Journal of Neuro-Oncology.

Phase I study of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466) in adults with solid tumors.

R. Benjamin, M. Burgess, G. Bodey, 1980, Cancer research.

A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.

D. Osoba, J. Pater, J. Latreille, 1992, European journal of cancer.

Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.

E. Eisenhauer, D. Macdonald, C. Sawka, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group.

E. Eisenhauer, F. Shepherd, M. Crump, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of L-alanosine using a daily x 3 schedule.

G. Bodey, M. Valdivieso, D. Stewart, 1982, Cancer treatment reports.

Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole

K. Bélanger, E. Eisenhauer, L. Whitfield, 1993, Investigational new drugs.

Kinetics of gallium nitrate, a new anticancer agent

R. Benjamin, A. Bedikian, M. Valdivieso, 1979, Clinical pharmacology and therapy.

Phase II study of sulofenur (LY186641) in measurable metastatic renal cancer.

I. Tannock, E. Eisenhauer, D. Stewart, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

D. Berry, J. Crowley, S. Groshen, 2010, Clinical Cancer Research.